Financial statements Phoenix Pharma Polska
Cash flow statement of Phoenix Pharma Polska
Company age:
Age:
24 y. 2 m. 5 d.
Share capital:
Share capital:
36 000 000 PLN
Cash inflows of PHOENIX PHARMA POLSKA
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Net cash from operating expenses | -1 971 447,64 | 3 783 351,92 | 1 315 547,17 | 3 393 599,38 | 4 056 421,20 |
| Net cash flow from investing activities | 260 221,30 | -4 150 776,26 | -178 986,34 | 1 062 498,26 | 780 935,28 |
| Net cash flow from financial activities | 0,00 | 0,00 | 0,00 | -2 000 000,00 | 0,00 |
| Total net cash flow | -1 711 226,34 | -367 424,34 | 1 136 560,83 | 2 456 097,64 | 4 837 356,48 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.